U.S. Media Stock News

Nuvation Bio has reported that in the first quarter of 2026 it generated US$83.23 million in revenue and US$5.4 million in net income, while the FDA has accepted a supplemental New Drug Application to update IBTROZI’s label with longer-term data in advanced ROS1-positive non-small cell lung cancer. These developments, alongside IBTROZI’s addition to NCCN guidelines for CNS cancers and strong intracranial response data, reinforce the company’s emerging role in treating ROS1-positive lung...

Wondering if Scholar Rock Holding at around US$46.45 is giving you fair value or a potential opportunity? This article walks through the key numbers in plain language so you can judge for yourself. The stock has seen mixed recent returns, with a 0.3% decline over the last 7 days and a 6.9% decline over the last month, alongside gains of 8.5% year to date, 49.9% over 1 year and a very large 3 year return, plus a 63.3% gain over 5 years. These moves have come as investors weigh ongoing...

T-Mobile US recently reported past first-quarter 2026 results showing revenue of US$23,107 million and net income of US$2,504 million, while also filing an omnibus shelf registration covering common and preferred stock, debt and other securities. The company is intensifying its network-resilience and broadband push through AI-powered emergency connectivity tools, expanded satellite services with Starlink, and new fiber joint ventures that could broaden its high-speed internet footprint to...

Niagen Bioscience (NAGE) is back on investors’ radar after reporting Q1 2026 results that exceeded consensus estimates, alongside the launch of its Niagen Plus telehealth platform and at-home prescription injection kits. See our latest analysis for Niagen Bioscience. Despite the upbeat Q1 report and new Niagen Plus initiatives, the stock’s recent momentum has been weak, with a 30 day share price return of a 6.26% decline and a year to date share price return of a 32.96% decline. The 3 year...

BigBear.ai Holdings (BBAI) just posted its Q1 2026 results, reporting US$34.44 million in sales and a net loss of US$56.76 million. The company also reaffirmed its full year 2026 revenue guidance of US$135 million to US$165 million. See our latest analysis for BigBear.ai Holdings. BigBear.ai’s Q1 update, including the US$53 million classified contract and growing AI platform exposure, comes after a 20.87% 1 month share price return but a 28.60% year to date share price decline. The 3 year...

Investors may be wondering whether Evercore, at around US$331 per share, still offers value or whether most of the easy gains are already behind it. The stock has delivered a 3.1% move over the last week and 7.9% over the past month, while year to date it is at a 5.7% decline against a 54.6% return over the last year, a 225.1% return over three years, and 154.1% over five years. Recent coverage has focused on Evercore's role in major advisory mandates and its position within capital markets...

Wondering if Hercules Capital's share price really reflects what you are getting for your money? This breakdown walks through what the current market price might be missing or already pricing in. Recently, the stock closed at US$16.40, with returns of 2.2% over 7 days, 8.5% over 30 days, 4.0% over 1 year and 67.6% over both 3 and 5 years, while the year to date return sits at a 13.0% decline. These moves sit against a backdrop of ongoing interest in income focused business development...

In early May 2026, Restaurant Brands International reported first-quarter 2026 results with revenue rising to US$2,264 million and net income reaching US$338 million, while also completing a US$59.86 million share repurchase tranche and affirming a quarterly dividend of US$0.65 per share. Beneath the headline beat, investors focused on the contrasting performance across brands, with strong Burger King momentum offset by weaker Popeyes results and higher cost concerns in the Restaurant...

Shopify (SHOP) just posted first quarter results with strong revenue growth, heavy investment in AI tools, and fresh guidance, yet the stock has pulled back sharply, catching investor attention across Wall Street and options markets. See our latest analysis for Shopify. That sharp post earnings pullback sits on top of a much weaker 2026 share price trend, with a year to date share price return of around negative 29%, even as 1 year total shareholder return is about 19% and 3 year total...

Praxis Precision Medicines (NasdaqGS:PRAX) reported that the FDA accepted New Drug Applications for ulixacaltamide and relutrigine. The company is preparing for potential U.S. launches following these NDA acceptances. Praxis also highlighted clinical progress for elsunersen, adding to momentum across its late-stage pipeline. For readers tracking central nervous system drug developers, Praxis sits at an important point in its evolution, with ulixacaltamide and relutrigine moving into formal...

Mach Natural Resources earnings and portfolio shift Mach Natural Resources (MNR) has just reported first quarter 2026 results that paired higher revenue with a net loss, while also redirecting capital toward oil weighted drilling projects and away from some gas focused activity. See our latest analysis for Mach Natural Resources. At a share price of $13.18, Mach Natural Resources has a year to date share price return of 17.16%, while the 1 year total shareholder return sits at 13.32%. This...

Why Mondelez International (MDLZ) Is Back on Investors’ Radar Mondelez International (MDLZ) has attracted fresh attention after recent share moves, with the stock showing mixed short term returns and a modest gain over the past month. This has prompted closer inspection of its fundamentals. See our latest analysis for Mondelez International. At a share price of $61.31, Mondelez’s recent 30-day share price return of 6.61% contrasts with a weaker 1-year total shareholder return of a 5.75%...

If you are wondering whether Gulfport Energy, at a last close of US$178.80, is attractively priced or if the easy gains are behind it, this article breaks down what the current share price might be implying about the stock's value. The stock has seen a 7.1% decline over the last week, a 13.9% decline over the last month, and a 13.3% decline year to date, set against a 94.6% return over the last 3 years and a 5.0% decline over the last year. Recent coverage has focused on Gulfport Energy's...

EIR Healthcare recently announced a partnership with MillerKnoll to integrate casework, furniture, and interior solutions directly into factory-built healthcare modules, aiming to deliver fully furnished, quality-checked clinics from day one. This move embeds MillerKnoll into an emerging offsite healthcare construction model that targets faster, more reliable delivery of behavioral health facilities funded by large public programs. We’ll now examine how embedding MillerKnoll’s solutions into...

Wondering if Adient at around US$21.86 is offering genuine value or just looks cheap on the surface? This article breaks down what that price might really mean for you. The stock has returned 3.8% over the last 7 days, 9.2% over the last 30 days, 14.8% year to date and 58.8% over the last year. However, the 3 year and 5 year returns of 38.7% and 53.9% declines show a much bumpier longer term picture. Recent coverage has focused on Adient's position in auto components and how investors are...

Wondering if Johnson & Johnson at around US$222 per share offers good value today, or if most of the opportunity has already played out. The stock is up 46.9% over the last year and 7.3% year to date, even after a 3.2% move over the past week and a 6.7% pullback over the past month. Recent headlines have focused on Johnson & Johnson's position in global healthcare and its role in key product categories. This helps frame how investors are thinking about its future cash generation and...

Sunstone Hotel Investors (SHO) caught investor attention after raising its 2026 net income guidance and reporting first quarter results that showed higher revenue, net income and earnings per share compared with a year earlier. See our latest analysis for Sunstone Hotel Investors. The raised 2026 guidance and stronger first quarter figures have coincided with a 15.0% 1 month share price return and a 13.4% year to date share price return. The 1 year total shareholder return of 28.7% points to...

This article explores whether Dollar General's current share price still offers value after a mixed few years, and walks through what the current market price might be implying about the stock. The stock recently closed at US$116.47, with returns of 0.5% over 7 days, a 3.9% decline over 30 days, a 14.9% decline year to date and a 29.2% gain over 1 year, compared with 3 year and 5 year returns of 42.9% and 38.6% declines respectively. Recent coverage has highlighted how investors are...

Why MSC Industrial Direct Stock Is Back in Focus MSC Industrial Direct (MSM) is back on investors’ radar after recent earnings and revenue shortfalls were followed by analyst upgrades linked to cost-cutting efforts, pricing changes, and a strong run in the share price. See our latest analysis for MSC Industrial Direct. At around $104.31 per share, MSC Industrial Direct is trading close to its recent 52 week high, with a 15% 30 day share price return and a 42.7% 1 year total shareholder...

If you are wondering whether Starbucks at around US$104 per share still offers value, it helps to step back and look at what the recent price action and fundamentals are really telling you. Over the last week the stock recorded a 1% decline, but over 30 days it returned 9.5% and year to date it is at 24.2%, with a 30.4% return over the past year that may be reshaping how investors think about its risk and reward profile. These moves sit against a backdrop where Starbucks continues to feature...

Why Constellation Energy stock is on investors’ radar Constellation Energy (CEG) has attracted fresh attention after its share price moved to around $311 at the latest close, with recent returns differing sharply between the past month, past 3 months and year to date. See our latest analysis for Constellation Energy. At a latest share price of $311.28, Constellation Energy has recently combined a 14.2% 30 day share price return with a weaker year to date share price return of 15.01%. Its 1...

How Otarmeni’s approval fits into the Regeneron Pharmaceuticals (REGN) story The FDA’s accelerated approval of Otarmeni, the first gene therapy for genetic hearing loss that Regeneron Pharmaceuticals (REGN) plans to provide free to U.S. patients, puts patient access and ESG considerations firmly in focus for investors. For you as a shareholder or potential buyer, this move sits at the intersection of medicine, brand equity, and long term platform value. It does not point directly to near term...

Why ConocoPhillips Stock Is Back in Focus ConocoPhillips (COP) is drawing fresh attention after Q1 2026 earnings topped expectations, updated guidance addressed Middle East related production uncertainty, and Norway approved the company’s plan to revive long idle North Sea gas fields. See our latest analysis for ConocoPhillips. Despite the recent news flow, ConocoPhillips’ share price has cooled, with a 12.82% 1 month share price decline and an 8.67% 7 day share price decline. However, the...

Investors may be wondering whether Marsh & McLennan Companies is starting to offer better value, or if the current share price already reflects its strengths. The stock last closed at US$166.03, with returns of a 1% decline over 7 days, a 3.8% decline over 30 days, a 9% decline year to date, a 25.9% decline over 1 year, and a 3.4% decline over 3 years, compared with a 33.1% gain over 5 years. Recent market attention has focused on how Marsh & McLennan Companies is positioned within the...